Late-onset attention problems — adult ADHD that wasn't there at 25
8 min read · Uplevel editorial
You used to be able to sit down and work. Not always effortlessly, but you could get in and stay in — a few hours of deep focus, a project moving, a real sense of completion at the end of the day. Now you sit down and something different happens. You open the document. A notification arrives. You check it. You check something adjacent to it. You return to the document and realize eight minutes have passed. You try again, drift again, and by noon you've produced a third of what you would have managed at 28 and you're carrying a low-grade shame about it that compounds across the week.
The question most people land on is: do I have ADHD? It's not a wrong question. But it might be a partial one.
The diagnostic conversation about adult-onset attention problems has two distinct tracks, and conflating them leads people to the wrong treatment and the wrong conclusions about themselves. The first track is genuine ADHD that was present earlier in life and is only becoming visible now. The second track is executive dysfunction that isn't ADHD but looks a lot like it from the inside — and has a different set of causes and, often, different solutions.
Both are real. Both deserve attention. And the standard clinical response, which tends toward an SSRI-or-stimulant binary, fits neither of them particularly well.
Actual ADHD doesn't originate in your late 30s. The DSM criteria require that symptoms have been present since childhood, even if they were never recognized or diagnosed. For many adults — particularly women, who were historically less likely to be identified as children — the ADHD was always there. What's changed is the scaffolding. At 22, life provides structure: classes with fixed schedules, assignments with deadlines, social routines that organize the day. At 35 or 42, you may be managing a career with high autonomy, a household, possibly children, with far less external structure and far higher executive load. The same underlying ADHD that was manageable with scaffolding becomes visible when the scaffolding comes down.
This is a meaningful distinction because it changes what you're working with. If the underlying neurology was always there, then stimulant medication and ADHD-specific coaching and behavioral strategies are on the table in a way that's evidence-based and appropriate. The conversation with your prescribing provider should include childhood history — not to interrogate you, but because it's clinically relevant. What were you like in school? Did you struggle with sustained attention or organization that you just found ways around? Did you read but rarely finish books? Did you procrastinate severely? These things have always mattered.
The second track is thornier because it's a long list. Executive dysfunction — difficulty sustaining focus, task-switching problems, inability to initiate, working memory lapses — can be downstream of a lot of things that aren't ADHD.
Chronic stress is at the top of the list. The prefrontal cortex, which manages executive function, is exquisitely sensitive to cortisol. Chronic elevation of cortisol — the kind that comes from years of sustained pressure, not acute stress — literally degrades the architecture of the prefrontal cortex. Synaptic connections in that region weaken under long-term cortisol exposure in ways that are measurable in imaging studies. If you have been operating in a sustained stress state for years and your executive function is declining, that's not a personality flaw and it may not be ADHD. It may be the predictable neurological result of what you've been living in.
Sleep architecture loss is next. The prefrontal cortex is the brain region most affected by sleep deprivation, which is both well-established and consistently underweighted in clinical conversations about attention. Slow-wave sleep, which declines with age and with stress, is when working memory resets and the prefrontal cortex consolidates its resources for the following day. If you are not getting adequate deep sleep — whether because of stress, alcohol use, untreated sleep apnea, or simply age-related sleep architecture changes — the executive dysfunction you're experiencing may be substantially sleep-driven. Untreated sleep apnea in particular is a significant and frequently missed contributor to cognitive problems in midlife adults, especially men, and it produces attention and memory symptoms that are nearly indistinguishable from ADHD on a symptom checklist.
The hormonal angle matters in ways that often go unaddressed. Estrogen and testosterone both have receptors in the prefrontal cortex. The cognitive changes that come with perimenopause — and that many women experience as a kind of sudden ADHD they never had before — are well-documented and have a clear mechanistic basis. Declining estrogen reduces dopaminergic tone in the prefrontal cortex. Declining testosterone in men has analogous effects on cognitive processing speed and working memory. Neither of these is ADHD. Both of them look like it.
Low thyroid function — even subclinical hypothyroidism, where TSH is elevated but still technically within range — produces brain fog, slow processing, and attention problems that are often missed because the numbers look "normal." Post-COVID cognitive effects are real, documented, and include executive dysfunction as a prominent feature. Mast cell activation disorder, which involves dysregulated histamine and other inflammatory mediators, can produce what's sometimes described as "brain fog" that's actually impaired working memory and reduced cognitive processing speed. None of these are ADHD. All of them can make someone think they have ADHD.
This matters because stimulants — amphetamines, methylphenidate — don't fix cortisol-damaged prefrontal architecture. They don't fix sleep apnea. They don't restore estrogen-mediated dopaminergic tone. They may temporarily compensate for some of these deficits, which creates the impression of "working," while the underlying causes continue unchecked. The SSRI option is even less well-fitted: SSRIs are not a treatment for ADHD, they don't address executive function directly, and for many people in this situation they produce the flatness and diminished motivation that makes cognitive performance worse rather than better.
A workup that's actually useful for this presentation should include thyroid function (TSH, free T3, free T4), a full hormonal panel for where you are in your hormonal life, a sleep study or at minimum a serious apnea screening, inflammatory markers if there's reason to suspect immune involvement, and a clinical conversation that specifically distinguishes childhood ADHD history from adult-onset presentation. That's a more thorough workup than most people get, and getting it requires advocating for yourself or finding a provider who thinks systematically about these things.
Where peptides may have a supporting role — and it's worth naming the ceiling of that role clearly — is in the context of this kind of workup, not as a replacement for it. Semax has been researched for its potential to support BDNF upregulation and dopaminergic modulation in ways that are relevant to prefrontal function and sustained attention. Selank has been studied for anxiolytic effects that may reduce the anxiety-driven attention fragmentation that many people with executive dysfunction experience. NAD+ has a mechanistic rationale for supporting mitochondrial energy in metabolically demanding neurons, including those in the prefrontal cortex. All of this research is early, mostly small-scale, and in the case of Semax and Selank primarily originating from Russian research institutions with limited Western replication. These are not FDA-approved compounds. They are not ADHD medications. They are adjunctive tools that some people find useful within a larger protocol, and the appropriate way to approach them is through a prescribing provider who can evaluate the full picture.
They're also not a substitute for addressing what's upstream. If the attention fragmentation is cortisol-driven, no peptide replaces the work of restructuring a life that's running too hot for too long. If it's sleep-driven, eight hours matters more than any supplement. If it's hormonal, that conversation with your prescribing provider is the load-bearing intervention. The tools that exist at the compounding pharmacy are downstream of those things, not instead of them.
The question worth sitting with is actually two questions. One: do you have ADHD — the underlying neurological pattern that was probably always there, that the structure of young adult life was hiding? Two: what else might be producing something that looks like ADHD, that has its own causes and its own solutions? Both questions are worth asking. The answer might be one or the other, or it might be both at once, which is its own complicated clinical picture that deserves more than a quick prescription and a follow-up in three months.
The attention fragmentation you're experiencing is real. The question is what it's made of.